Publicidad
Caso clínico 12 de abril de 2021

Metástasis óseas quiescentes persistentemente positivas en gammagrafía ósea: valor añadido de la imagen PET (a propósito de un caso)

Referenciar Imprimir Descargar PDF

Referencias

  1. Informe-SEOM-cifras-cancer-2019.pdf. https://seom.org/dmcancer/wp-content/uploads/2019/Informe-SEOM-cifras-cancer-2019.pdf
  2. Hayashi N, Costelloe CM, Hamaoka T, et al. A prospective study of bone tumor response assessment in metastatic breast cancer. Clin Breast Cancer 2013; 13:24-30.
  3. Coleman R, Body JJ, Aapro M, et al. ESMO Guidelines Working Group. Bone health in cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol Off J Eur Soc Med Oncol 2014; 25 Suppl 3:iii124-137.
  4. O’Sullivan GJ, Carty FL, Cronin CG. Imaging of bone metastasis: An update. World J Radiol 2015; 7:202-11.
  5. Woolf DK, Padhani AR, Makris A. Assessing response to treatment of bone metastases from breast cancer: what should be the standard of care? Ann Oncol Off J Eur Soc Med Oncol 2015; 26:1048-57.
  6. Al-Muqbel KM, Yaghan RJ. Effectiveness of 18F-FDG-PET/CT vs bone scintigraphy in treatment response assessment of bone metastases in breast cancer. Medicine (Baltimore). 2016; 95:e3753.
  7. NCCN Clinical Practice Guidelines in oncology (NCCN Guidelines). Breast cancer version 1.2018. www.NCCN.org
  8. Liu T, Cheng T, Xu W, et al. A meta-analysis of 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with breast cancer. Skeletal Radiol 2011; 40:523-31.
  9. National Institute for Health and Clinical Excellence (NICE). The guidelines manual 2009,http://www.nice.org. uk/media/5F2/44/The_guidelines_manual_2009
  10. Grávalos C, Rodríguez C, Sabino A, et al. SEOM Clinical Guideline for bone metastases from solid tumours (2016). Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex. 2016; 18:1243-53.